| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.06 | 0.2 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | 0.07 | 0.2 |
| mRNA | isonicotinohydroxamic acid | CTRPv2 | pan-cancer | AAC | -0.063 | 0.2 |